| For: | Yang Y, Fu KZ, Pan G. Role of Oncostatin M in the prognosis of inflammatory bowel disease: A meta-analysis. World J Gastrointest Surg 2024; 16(1): 228-238 [PMID: 38328320 DOI: 10.4240/wjgs.v16.i1.228] |
|---|---|
| URL: | https://www.wjgnet.com/1007-9327/full/v16/i1/228.htm |
| Number | Citing Articles |
| 1 |
Eguzkiñe Diez-Martin, Leidi Hernandez-Suarez, Carmen Muñoz-Villafranca, Leire Martin-Souto, Egoitz Astigarraga, Andoni Ramirez-Garcia, Gabriel Barreda-Gómez. Inflammatory Bowel Disease: A Comprehensive Analysis of Molecular Bases, Predictive Biomarkers, Diagnostic Methods, and Therapeutic Options. International Journal of Molecular Sciences 2024; 25(13) doi: 10.3390/ijms25137062
|
| 2 |
Antonio Mestrovic, Nikola Perkovic, Dorotea Bozic, Marko Kumric, Marino Vilovic, Josko Bozic. Precision Medicine in Inflammatory Bowel Disease: A Spotlight on Emerging Molecular Biomarkers. Biomedicines 2024; 12(7) doi: 10.3390/biomedicines12071520
|
| 3 |
Satyajit Tripathy. The Dual Nature of Oncostatin M: Context-Dependent Mediator of Immunity and Fibrosis. Cell Biochemistry and Biophysics 2025; 84(1) doi: 10.1007/s12013-025-01954-5
|
| 4 |
Seung Min Hong, Dong Hoon Baek. Diagnostic Procedures for Inflammatory Bowel Disease: Laboratory, Endoscopy, Pathology, Imaging, and Beyond. Diagnostics 2024; 14(13) doi: 10.3390/diagnostics14131384
|
| 5 |
Faranak Bahramimehr, Axel Guthart, Stefanie Kurz, Yuanping Hai, Mona Dawood, Rümeysa Yücer, Nasim Shahhamzehei, Ralf Weiskirchen, Wilfried Roth, Wolfgang Stremmel, Gerhard Bringmann, Thomas Efferth. Drug Repurposing to Inhibit Oncostatin M in Crohn’s Disease. Molecules 2025; 30(9) doi: 10.3390/molecules30091897
|
| 6 |
Wujuan Hao, Lan Gu, Renmin Zhou, Cuilan Huang, Xuyang Wang, Yanshan Liu, Qiong Lin. Association of alterations in transcriptomics and intestinal immune responses with Bifidobacterium longum BAA2573 in improving dextran sulfate sodium-induced colitis. BMC Gastroenterology 2025; 25(1) doi: 10.1186/s12876-025-04116-2
|
| 7 |
Vedran Tomašić, Alen Bišćanin, Dominik Kralj, Petra Ćaćić, Doris Ogresta. Unveiling Ulcerative Colitis - A Comprehensive Approach to Understanding and Management. 2024; doi: 10.5772/intechopen.1007643
|
| 8 |
Ahmed Mansur Kadhim, Dheyaa Jabbar Kadhim, Raghad Jawad Hussein. Association of novel serum biomarkers (Oncostatin M, 90K/Mac-2 BP, and IL-12 p40) with adalimumab target trough level achievement and response in Iraqi inflammatory bowel disease patients: A cross-sectional real-world study. Pharmacia 2026; 73 doi: 10.3897/pharmacia.73.e179453
|
| 9 |
Alina-Ecaterina Jucan, Georgiana-Elena Sarbu, Vasile-Claudiu Mihai, Carmen Atodiresei, Simona Juncu, Ioana-Ruxandra Mihai, Mariana Pavel-Tanasa, Daniela Constantinescu, Mihaela Dranga, Otilia Nedelciuc, Diana-Gabriela Iosep, Mihai Danciu, Smaranda Diaconescu, Georgiana-Emmanuela Gîlca-Blanariu, Andrei Mihai Andronic, Elena Toader, Vasile-Liviu Drug, Cristina Cijevschi Prelipcean, Catalina Mihai. Serum Oncostatin M in Ulcerative Colitis Patients and Its Relation to Disease Activity. International Journal of Molecular Sciences 2025; 27(1) doi: 10.3390/ijms27010307
|
| 10 |
Asmaa Ibrahim, Fatma Rageh, Shaymaa Abdelraheem Abdelhady, Rasha Elgamal, Mohamed A. Sakr, Mohamed Medhat, Samar S. Ahmed, Hend A. Yassin, Yasmine N. Kamel, Mai Hamdy Rashad, Almaza Ali Salim, Mohamed Mahmoud Elhoseeny, Amira A.A. Othman, Moamen A.I. Mazen, Manar Ezzelarab Ramadan. Oncostatin level and Tumour necrosis factor-alpha gene polymorphism in predicting Blastocystis infection in inflammatory bowel disease. Acta Tropica 2026; 280 doi: 10.1016/j.actatropica.2026.108199
|
| 11 |
Zahraa Nasser Ali, Hiba Resheed Behayaa, Ahmed Abdul-Hussein Gburi Alhilly. Diagnostic performance of serum oncostatin M and MMP-9 in differentiating disease activity in Crohn's disease and ulcerative colitis. European Journal of Clinical and Experimental Medicine 2026; 24(2) doi: 10.15584/ejcem.2026.2.16
|
| 12 |
Hiroki Kurumi, Yoshihiro Yokoyama, Takehiro Hirano, Kotaro Akita, Yuki Hayashi, Tomoe Kazama, Hajime Isomoto, Hiroshi Nakase. Cytokine Profile in Predicting the Effectiveness of Advanced Therapy for Ulcerative Colitis: A Narrative Review. Biomedicines 2024; 12(5) doi: 10.3390/biomedicines12050952
|